eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Subscription
SCImago Journal & Country Rank

 
1/2005
vol. 1
 
Share:
Share:
more
 
 
abstract:

ORIGINAL PAPER
Combined interferon-alpha-2b and ribavirin therapy in patients with recurring chronic hepatitis C (genotype 1) following liver transplantation in Hungary

Gabriella Lengyel
,
László Kóbori
,
Imre Fehérvári
,
Balázs Nemes
,
Dénes Görög
,
Attila Patonai
,
Enikö Sárváry
,
Marina Varga
,
Krisztina Hagymási
,
Ferenc Perner
,
János Fehér
,
Zsolt Tulassay

Arch Med Sci 2005; 1, 1: 8-12
Online publish date: 2005/05/06
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Objectives: Hepatitis C virus (HCV) recurrence after liver transplantation is universal and leads to chronic hepatitis and cirrhosis. Combined interferon and ribavirin therapy represents the accepted treatment for recurrent chronic hepatitis C following liver transplantation, according to the literature. Our aim was to assess the efficacy and safety of the recommended combined interferon and ribavirin therapy, and evaluation of the rate of long-term remission under Hungarian circumstances.
Methods: 16 patients with chronic recurrent hepatitis C, who had been HCV-PCR positive (genotype 1b), received combined treatment with interferon-alpha-2b (3 MU three times a week) and ribavirin (800-1000 mg daily) for 12 months following transplantation. 12 patients have completed the therapy. Liver biopsies were performed before commencing and after concluding treatment in every patient. Virological responses at completion of the 12-month-long treatment and at the end of the subsequent 6-month-long follow-up period served as endpoints for the evaluation.
Results: At completion of the 12-month-long treatment 3 patients became HCV-PCR-negative. All three patients remained negative at six months following completion of the treatment.
Conclusions: Efficacy and safety of the combined treatment of transplanted patients were similar to the therapeutic results in patients with chronic hepatitis C without liver transplantation.
keywords:

chronic hepatitis C, interferon, ribavirin, liver transplantation

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe